Tedisamil sesquifumarate

This classification denotes an antiarrhythmic agent with the molecular formula 2C19H32N2.3C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y4HRG433UU, chemically known as bis(3',7'-bis(cyclopropylmethyl)spiro(cyclopentane-1,9'-(3,7)diazabicyclo(3.3.1)nonane))dihydrogen tris((2e-but-2-enedioate), but more generally known as tedisamil sesquifumarate, which bears US NIH Compound Identifier 56841543. European Medicines Agency schedules Tedisamil sesquifumarate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22754. Most nations, for tariff and trade purposes, schedule tedisamil sesquifumarate under HS 29333999 and SITC 51574. As of Q4 2014, TEDISAMIL SESQUIFUMARATE remains US FDA's Preferred Term for this commodity. Tedisamil sesquifumarate bears US NLM identifiers UMLS ID C2348658 and NCI Concept Code C73802. SMILES: C1CC2(C3CN(CC2CN(C3)CC4CC4)CC5CC5)CC1.C1CC2(C3CN(CC2CN(C3)CC4CC4)CC5CC5)CC1.C(=C/C(=O)O)\C(=O)O.C(=C/C(=O)O)\C(=O)O.C(=C/C(=O)O)\C(=O)O.